Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Financing Activities: 2012-2025

Historic Cash from Financing Activities for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to $207.1 million.

  • Phibro Animal Health's Cash from Financing Activities rose 155.95% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $252.7 million, marking a year-over-year increase of 778.10%. This contributed to the annual value of $207.1 million for FY2025, which is 3160.49% up from last year.
  • Phibro Animal Health's Cash from Financing Activities amounted to $207.1 million in FY2025, which was up 3,160.49% from -$6.8 million recorded in FY2024.
  • Over the past 5 years, Phibro Animal Health's Cash from Financing Activities peaked at $207.1 million during FY2025, and registered a low of -$17.0 million during FY2021.
  • Moreover, its 3-year median value for Cash from Financing Activities was $27.0 million (2023), whereas its average is $75.8 million.
  • As far as peak fluctuations go, Phibro Animal Health's Cash from Financing Activities crashed by 141.52% in 2021, and later soared by 3,160.49% in 2025.
  • Over the past 5 years, Phibro Animal Health's Cash from Financing Activities (Yearly) stood at -$17.0 million in 2021, then surged by 196.16% to $16.3 million in 2022, then surged by 65.13% to $27.0 million in 2023, then slumped by 125.08% to -$6.8 million in 2024, then spiked by 3,160.49% to $207.1 million in 2025.